ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,807 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenNeurimmune Subone AG
Neurimmune Subone AG Logo
Verified· 3 sources

Neurimmune Subone AG

Summary

About the company

Neurimmune Subone AG is a biopharmaceutical company that translates human immune memory into antibody therapeutics. It develops monoclonal antibody candidates for indications including Alzheimer’s disease, amyotrophic lateral sclerosis, spinal cord injury, ATTR cardiomyopathy and type‑2 diabetes, applying its Reverse Translational Medicine™ (RTM™) technology platform and pursuing discovery, early clinical development and strategic partnerships.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Antibody therapeutics
Antibody therapeutics for protein aggregation disorders, developed as fully human antibody candidates for selective binding to pathological protein forms and for sparing physiological target structures.
Amyloid depletion
Selective removal of misfolded or aggregated proteins using human antibodies to label pathological target structures and enable their immune-mediated clearance.
Reverse Translational Medicine™ (RTM™)
Research platform for deriving fully human therapeutic antibodies from genetic blueprints of immune cells from older people and for identifying selective, high-affinity candidates.
Pipeline of clinical and preclinical antibody candidates
Development of antibody candidates against ATTR cardiomyopathy, amyotrophic lateral sclerosis, spinal cord injury, AL amyloidosis and Alzheimer’s disease.
Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 1 reviews across all connected sources

Sources
GGoogle51
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Knowledge

No knowledge articles yet

Once Neurimmune Subone AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Neurimmune Subone AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Neurimmune Subone AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Neurimmune Subone AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 18
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-113.902.651
Founded
2007 · 19 years
Last commercial register change
September 8, 2021
Employees
1 to 10

Similar companies

AR
Akademische Raumfahrt Initiative Schweiz (ARIS)
Dübendorf
BS
BIO-TECHNOPARK Schlieren-Zürich
Schlieren
CA
Contrec AG
Dietikon
SR
Swiss Rescue Innovation GmbH
Wallisellen